medigraphic.com
SPANISH

Revista Mexicana de Patología Clínica y Medicina de Laboratorio

ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number 4

<< Back

Rev Mex Patol Clin Med Lab 2006; 53 (4)

Quality cervicouterine sampling for early detection of cervicouterine cancer

Rodríguez-Frausto M, Lunar T, Lara-Martínez GM, López-Gómez Y
Full text How to cite this article

Language: Spanish
References: 8
Page: 229-234
PDF size: 85.19 Kb.


Key words:

Quality, detection opportune of cancer.

ABSTRACT

Introduction: In Mexico Cervico Uterine Cancer (CuCa) is serious problem, with a mortality rate of 9.5/100,000 women. The Mexican established Public Health Policy is to improve detection and quality attention through compliance to The Official Mexican Standard: NOM.014, SSA-2 1994.
Goal: To evaluate compliance to NOM.014, SSA-2 1994.
Material and methods: By means of a descriptive and cross-sectional design, quality assessment of the sampling process for Opportune Detection of CaCu (DOC) was undertaken. One hundred events were included through simple availability, from DOC modules of Family Care Centers at Leon, Guanajuato, Mexico. By means of direct observation and user survey through a previously developed check list in accordance to NOM.014, SSA-2 1994 classifying as attached or not attached to the Standard in the Technical Procedure, Registry and Affectivity chapters.
Results: A 60% attachment to the established standard was found on Technical topic, Registry 47%, affectivity 55%; -11% of participants do not contemplate returning to practice the test.
Conclusions: Standard Compliance is low. It is strongly recommended to educate, to train and top supervise the operative areas properly on this activity, strengthening the detected strategic-important issues. Having 11% of customers reluctant to return constitutes a risk group and potential promoters against DOC Prevention Program.


REFERENCES

  1. Lázaro MJM, Muniesa SJA, Pardo MA. www.opolanco.es/Apat/Boletin2/CITOLOGIA.html (Págs. 1, 6)

  2. www.esmas.com/salud/home/sexualidad/413959.html

  3. Translation by Javier Alonso y Vivianne Schnitzer www.med.umuch.edu/1libr/guides/paps.htm (Editores de Hispánica) (Pág. 1) (Abril 2004).

  4. Robles SC et al. Trends in cervical cancer mortality in the Americas. Bulletin of PAHO 1996; 30(4): 290-301.

  5. Secretaría de Salud. Norma Oficial Mexicana NOM:014, SSA-2.1994 para la Prevención, Detección, Diagnóstico, Tratamiento, Control y Vigilancia Epidemiológica del Cáncer Cervicouterino. Diario Oficial, 6 de marzo de 1998. Págs. 50-67.

  6. Cuzik J, Hol TG et al. Human papillomavirus type DNA in cervical smears as predictor of high grade cervical cancer. Lancet 1992: 339-360.

  7. Elias A, Lingthours G, Bekker B. The significance of endocervical cell in the diagnosis of cervical epithelial chage. Acta Cytil 1993; 27: 227-235.

  8. Manual de Normas y Procedimientos para Control del Cáncer del Cuello de Útero OPS, 1990.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Patol Clin Med Lab. 2006;53